Characterization of non-small cell lung cancer transforming to small cell lung cancer and its response to EGFR-TKI: a case report

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have demonstrated significant survival benefits for advanced non-small cell lung cancer (NSCLC) patients with sensitive EGFR mutations. However, patients with EGFR-TKI treatment often develop acquired resistance subsequently. Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Guotao, Liu, Weiwei, Shang, Yanhong, Huo, Ran, Shi, Xiaoliang, Wang, Yanan, Li, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848416/
https://www.ncbi.nlm.nih.gov/pubmed/35282065
http://dx.doi.org/10.21037/atm-21-6991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848416/
https://www.ncbi.nlm.nih.gov/pubmed/35282065
http://dx.doi.org/10.21037/atm-21-6991

Ejemplares similares